Moshe Alafi, 10% Owner at Intra-Cellular Therapies, Inc. (ITCI), bought 35,000 shares at $14.75 ($516K) on 2014-11-28, disclosed to the SEC on 2014-11-28.
Open-market purchase of $516k ITCI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| ITCI | BUY | 2016-11-17 | $493K | — | Filing → |
| ITCI | BUY | 2014-12-03 | $21K | — | Filing → |
| ITCI | BUY | 2014-11-21 | $15K | — | Filing → |